Anne-Sophie Carrese Overview
- Firm
- Elaia Partners
- Primary Position
-
Managing Partner...
- Primary Industry
-
Information Technology
- Active Board Seats
-
3
- Med. Deal Size
-
- Med. Valuation
-
Anne-Sophie Carrese General Information
Biography
Ms. Anne-Sophie Carrese serves as a Managing Partner & Board Member at Elaia Partners. She is also the Member of the Supervisory & Monitoring Committee at Programme des Investissements d'Avenir. She joined Elaia in September 2017 as a Partner. She serves as a Board Member at Minos Biosciences. Previously, she served as a Board Member at Actility and Aledia. Firstly, as a test engineer in aircraft engines, she negotiates critical partnerships with large industrial corporates, notably Snecma (Rafale) and Rolls Royce, and manages the production team. She joined the Direction du Trésor to finance mobility projects abroad, then became the investment director of the renewable energies infrastructure department at the Caisse des Dépôts. She joins the Bpifrance Investissement to contribute to the launch of the Mezzanine Fund and to structure the Eco Technologies Fund. She studied Ecole Polytechnique Corps de l'Armement (X 1995 and has expertise in Energy, Aeronautics, Automotive, IoT, Deeptech.
Contact Information
Address
- 21 Rue D'uzes
- 75002 Paris
- France
Anne-Sophie Carrese Positions (2)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Elaia Partners | Investor | Managing Partner & Board Member | Paris, France | Venture Capital | |
Programme des Investissements d'Avenir | Investor | Member of the Supervisory & Monitoring Committee | Paris, France | Venture Capital |
Anne-Sophie Carrese Board Seats (3)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Elaia Partners | Paris, France | ||||
Minos Biosciences | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Paris, France | |
Qantev | Business/Productivity Software | Privately Held (backing) | Venture Capital-Backed | Paris, France |
Anne-Sophie Carrese Lead Partner on Deals (14)
Anne-Sophie Carrese has been the lead partner on 14 deals. Their latest deal was with Qantev, a business/productivity software company. The deal was made for on 27-Sep-2024.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Qantev | 27-Sep-2024 | Later Stage VC (Series B) | Completed | Business/Productivity Software | Paris, France | |
Hema.to | 26-Jun-2023 | Completed | Decision/Risk Analysis | Munich, Germany | ||
Qantev | 25-Oct-2022 | Completed | Business/Productivity Software | Paris, France | ||
Azalea Vision | 08-Jul-2021 | Completed | Therapeutic Devices | Ghent, Belgium | ||
Quantum Dice | 01-Jun-2021 | Completed | Network Management Software | Oxford, United Kingdom | ||
Minos Biosciences | 15-Apr-2021 | Completed | Biotechnology | Paris, France | ||
Moments Lab | 30-Mar-2021 | Completed | Multimedia and Design Software | Boulogne-Billancourt, France | ||
Qantev | 12-Nov-2020 | Completed | Business/Productivity Software | Paris, France | ||
Hummink | 08-Oct-2020 | Seed Round | Completed | Other Hardware | Paris, France | |
Quortex | 18-Jun-2020 | Seed Round | Completed | Business/Productivity Software | Cesson Sevigne, France |
Anne-Sophie Carrese Network (193)
Board Members (51)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Stefan Kuentz | Actility | Swisscom Ventures | Paris, France | |
Giorgio Anania Ph.D | Aledia | Self | Echirolles, France | |
Actility | Orange Ventures | Paris, France | ||
Minos Biosciences | Minos Biosciences | Paris, France | ||
Actility | Bosch Ventures | Paris, France |
Portfolio Executives (74)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Tarik Dadi | Qantev | Co-Founder, Chief Executive Officer & President | 27-Sep-2024 | Paris, France |
Hadrien De March Ph.D | Qantev | Co-Founder, Chief Technology Officer & General Manager | 27-Sep-2024 | Paris, France |
Hema.to | Co-Founder, Co-Chief Executive Officer, Managing Director, and CINO | 26-Jun-2023 | Munich, Germany | |
Hema.to | Interim Chief Financial Officer | 26-Jun-2023 | Munich, Germany | |
Hema.to | Co-Founder, Chief Research Officer & Principal Software Developer | 26-Jun-2023 | Munich, Germany |
Anne-Sophie Carrese Affiliated Funds (9)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
SPI Fund | Bpifrance | Buyout | Closed | 2015 | ||||
ETI 2020 | Bpifrance | Growth/Expansion | Closed | 2014 | ||||
Nuclear Enterprise Development Fund | Bpifrance | Infrastructure Core | Closed | 2014 | ||||
Ecotechnologies Fund | Bpifrance | Venture - General | Closed | 2011 | ||||
Elaia Digital Ventures 4 | Elaia Partners | Venture Capital - Early Stage | Closed | 2021 |
Anne-Sophie Carrese FAQs
-
Who is Anne-Sophie Carrese?
Ms. Anne-Sophie Carrese serves as a Managing Partner & Board Member at Elaia Partners.
-
How much does Anne-Sophie Carrese typically invest?
Anne-Sophie Carrese's median deal size is
. -
What is Anne-Sophie Carrese’s main position?
Anne-Sophie Carrese’s primary position is Managing Partner & Board Member.
-
What are the contact details for Anne-Sophie Carrese?
Anne-Sophie Carrese’s email address is as
and his phone number is +33 01 . -
How many active board seats does Anne-Sophie Carrese hold?
Anne-Sophie Carrese holds 3 board seats including Elaia Partners, Minos Biosciences, and Qantev.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »